FMO5 and Cognitive impairment: APO Treatment Prevented Surgery-Induced Cognitive Impairment, Decreased PV Expression, and Increased Inflammatory Responses and Oxidative Stress in the Hippocampus, at Least Partially, by Inhibiting NADPH Oxidase Activity